Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial
None
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2012
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/28167 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839564098735439872 |
|---|---|
| author | Otero, Y. de Diego Quintero-Navarro, C. Calvo-Medina, Rocio Heredia-Farfan, R. Sanchez-Salido, L. Lima-Cabello, E. Higuero-Tapiador, A. Arco-Herrera, I. del Fernandez-Carvajal, I. Ferrando-Lucas, T. Perez-Costillas, L. |
| author_facet | Otero, Y. de Diego Quintero-Navarro, C. Calvo-Medina, Rocio Heredia-Farfan, R. Sanchez-Salido, L. Lima-Cabello, E. Higuero-Tapiador, A. Arco-Herrera, I. del Fernandez-Carvajal, I. Ferrando-Lucas, T. Perez-Costillas, L. |
| author_sort | Otero, Y. de Diego |
| collection | InTech Open eBooks |
| description | None |
| doi_str_mv | 10.5772/29480 |
| first_indexed | 2025-08-04T22:03:54Z |
| format | Electronic Book Chapter |
| fullrecord | <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>InTech-28167</identifier><datestamp>2012-02-15</datestamp>
<dc:title>Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial</dc:title>
<dc:creator>Y. de Diego Otero</dc:creator>
<dc:creator>C. Quintero-Navarro</dc:creator>
<dc:creator>Rocio Calvo-Medina</dc:creator>
<dc:creator>R. Heredia-Farfan</dc:creator>
<dc:creator>L. Sanchez-Salido</dc:creator>
<dc:creator>E. Lima-Cabello</dc:creator>
<dc:creator>A. Higuero-Tapiador</dc:creator>
<dc:creator>I. del Arco-Herrera</dc:creator>
<dc:creator>I. Fernandez-Carvajal</dc:creator>
<dc:creator>T. Ferrando-Lucas</dc:creator>
<dc:creator>L. Perez-Costillas</dc:creator>
<dc:subject>Health Sciences</dc:subject>
<dc:description>None</dc:description>
<dc:publisher>IntechOpen</dc:publisher>
<dc:date>2012-02-15</dc:date>
<dc:type>Chapter, Part Of Book</dc:type>
<dc:identifier>https://www.intechopen.com/chapters/28167</dc:identifier>
<dc:identifier>doi:10.5772/29480</dc:identifier>
<dc:language>en</dc:language>
<dc:relation>ISBN:978-953-307-865-6</dc:relation>
<dc:rights>https://creativecommons.org/licenses/by/3.0/</dc:rights>
<dc:source>https://www.intechopen.com/books/728 ; Latest Findings in Intellectual and Developmental Disabilities Research</dc:source>
</oai_dc:dc> |
| id | InTech-28167 |
| institution | Matheson Library |
| isbn | 978-953-307-865-6 |
| language | English |
| last_indexed | 2025-08-04T22:03:54Z |
| publishDate | 2012 |
| publisher | IntechOpen |
| record_format | intech |
| spelling | InTech-281672012-02-15 Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial Y. de Diego Otero C. Quintero-Navarro Rocio Calvo-Medina R. Heredia-Farfan L. Sanchez-Salido E. Lima-Cabello A. Higuero-Tapiador I. del Arco-Herrera I. Fernandez-Carvajal T. Ferrando-Lucas L. Perez-Costillas Health Sciences None IntechOpen 2012-02-15 Chapter, Part Of Book https://www.intechopen.com/chapters/28167 doi:10.5772/29480 en ISBN:978-953-307-865-6 https://creativecommons.org/licenses/by/3.0/ https://www.intechopen.com/books/728 ; Latest Findings in Intellectual and Developmental Disabilities Research |
| spellingShingle | Health Sciences Otero, Y. de Diego Quintero-Navarro, C. Calvo-Medina, Rocio Heredia-Farfan, R. Sanchez-Salido, L. Lima-Cabello, E. Higuero-Tapiador, A. Arco-Herrera, I. del Fernandez-Carvajal, I. Ferrando-Lucas, T. Perez-Costillas, L. Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial |
| title | Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial |
| title_full | Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial |
| title_fullStr | Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial |
| title_full_unstemmed | Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial |
| title_short | Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial |
| title_sort | oral ascorbic acid and alpha tocopherol to reduce behavioural problems in young patients affected of fragile x syndrome a randomized double blind placebo controlled phase ii pilot trial |
| topic | Health Sciences |
| url | https://www.intechopen.com/chapters/28167 |
| work_keys_str_mv | AT oteroydediego oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT quinteronavarroc oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT calvomedinarocio oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT herediafarfanr oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT sanchezsalidol oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT limacabelloe oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT higuerotapiadora oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT arcoherreraidel oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT fernandezcarvajali oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT ferrandolucast oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial AT perezcostillasl oralascorbicacidandalphatocopheroltoreducebehaviouralproblemsinyoungpatientsaffectedoffragilexsyndromearandomizeddoubleblindplacebocontrolledphaseiipilottrial |